These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6275788)

  • 41. Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014.
    Golparian D; Ohlsson A; Janson H; Lidbrink P; Richtner T; Ekelund O; Fredlund H; Unemo M
    Euro Surveill; 2014 Jul; 19(30):. PubMed ID: 25108533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan.
    Deguchi T; Yasuda M; Hatazaki K; Kameyama K; Horie K; Kato T; Mizutani K; Seike K; Tsuchiya T; Yokoi S; Nakano M; Yoh M
    Emerg Infect Dis; 2016 Jan; 22(1):142-4. PubMed ID: 26689442
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
    Yu RX; Yin Y; Dai XQ; Chen SC; Han Y; Zheng BJ; Zhang GY; Chen XS
    Sex Transm Dis; 2017 Apr; 44(4):197-201. PubMed ID: 28282644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
    Hook EW; Pinson GB; Blalock CJ; Johnson RB
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1720-1. PubMed ID: 8807070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis.
    Ito S; Yasuda M; Hatazaki K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Deguchi T
    J Antimicrob Chemother; 2016 Sep; 71(9):2559-62. PubMed ID: 27246232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory-acquired gonococcal conjunctivitis: successful treatment with single-dose ceftriaxone.
    Zajdowicz TR; Kerbs SB; Berg SW; Harrison WO
    Sex Transm Dis; 1984; 11(1):28-9. PubMed ID: 6324398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
    Friedland LR; Kulick RM; Biro FM; Patterson A
    Ann Emerg Med; 1996 Mar; 27(3):299-304. PubMed ID: 8599487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.
    Pabst KM; Siegel NA; Smith S; Black JR; Handsfield HH; Hook EW
    Sex Transm Dis; 1989; 16(3):148-51. PubMed ID: 2510329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1996 Dec; 34(12):3214-7. PubMed ID: 8940476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis.
    Zajdowicz TR; Sanches PL; Berg SW; Kerbs SB; Newquist RL; Harrison WO
    Br J Vener Dis; 1983 Jun; 59(3):176-8. PubMed ID: 6303490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating
    Igawa G; Yamagishi Y; Lee KI; Dorin M; Shimuta K; Suematsu H; Nakayama SI; Mikamo H; Unemo M; Ohnishi M
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group.
    Handsfield HH; Dalu ZA; Martin DH; Douglas JM; McCarty JM; Schlossberg D
    Sex Transm Dis; 1994; 21(2):107-11. PubMed ID: 9071422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug-resistant
    Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The combination of rifampicin-erythromycin in the treatment of gonococcal urethritis in men.
    Panikabutra K; Ariyarit C; Chitwarakorn A; Wongba C
    J Med Assoc Thai; 1985 Nov; 68(11):579-82. PubMed ID: 3936898
    [No Abstract]   [Full Text] [Related]  

  • 55. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.
    Kidd S; Moore PC; Kirkcaldy RD; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Venkatasubramanian L; Ghanem KG; Hook EW
    Sex Transm Dis; 2015 Aug; 42(8):434-9. PubMed ID: 26165435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.
    Yasuda M; Hatazaki K; Ito S; Kitanohara M; Yoh M; Kojima M; Narita H; Kido A; Miyata K; Deguch T
    Sex Transm Dis; 2017 Mar; 44(3):149-153. PubMed ID: 28178112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae in Kingston, Jamaica: 1990-1991.
    Knapp JS; Brathwaite AR; Hinds A; Duncan W; Rice RJ
    Sex Transm Dis; 1995; 22(3):155-9. PubMed ID: 7652657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
    Lefebvre B; Martin I; Demczuk W; Deshaies L; Michaud S; Labbé AC; Beaudoin MC; Longtin J
    Emerg Infect Dis; 2018 Feb; 24(2):381-3. PubMed ID: 29131780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.